UM Sylvester Comprehensive Cancer Care Center

UM Sylvester Comprehensive Cancer Care Center

This month, C3 made a cash donation in support of the Miami Dolphins Cycling Challenge.   The Dolphins Cycling Challenge (“DCC”) is a two-day tri-county charity cycling event coordinated by the Miami Dolphins Foundation. The purpose of the DCC is to increase cancer awareness, encourage healthy hobbies, and raise funds for the University of Miami Sylvester Comprehensive Cancer Center.

On February 3, 2011, the Miami Dolphins Foundation presented the UM Sylvester Comprehensive Cancer Center with a check for $533,106, which represented 100% of the funds raised by more than 300 adult and 100 kid riders who participated in the inaugural Dolphins Cycling Challenge in November 2010. The check is one of the largest gifts ever to Sylvester from a single event.

The Unversity of Miami’s Sylvester Comprehensive Cancer Center opened in 1992 to provide comprehensive cancer services to the South Florida community. Sylvester serves as the hub for cancer diagnosis and treatment for UHealth, the University of Miami Health System. In 2003, Sylvester expanded its cancer services to patients in Broward and Palm Beach with the opening of Sylvester at Deerfield Beach. A third facility, Sylvester at Kendall, was opened in 2009 to serve patients in southern Miami-Dade county. Since its founding, Sylvester has transformed cancer research and treatment in South Florida and beyond.

Sylvester handles approximately 1,300 inpatient admissions annually, performs nearly 3,000 surgical procedures, and treats more than 4,300 new cancer patients. All Sylvester physicians are on the faculty of the Miller School of Medicine, South Florida’s only academic medical center.

Today there are more than 258,000 outpatient visits at the cancer center and more than 250 physicians and scientists working together to realize Harcourt Sylvester Jr.’s vision of a comprehensive cancer center. In addition, Sylvester physicians and scientists are engaged in approximately 230 clinical trials and receive more than $41 million annually in research grants.